Dealing with Issues of Obtaining Sufficient Tissue in Performing Biomarker Testing

David L. Rimm, MD, PhD; Roy S. Herbst, MD, PhD

Drs. Roy Herbst and David Rimm review some of the problems associated with obtaining enough tissue to perform biomarker testing, the need to triage tissue to ensure that standard of care tests are completed, and the potential role of liquid biopsies

Related Videos

October 7, 2016

Common Issues in Treating Patients with HR+/ HER2-Negative Metastatic Breast Cancer

Dr Hope Rugo discusses some of the choices and challenges she’s faced with in treating patients with HR+/ HER2-negative metastatic breast cancer with the goal of helping patients live as long as possible and with the best quality of life.

January 30, 2014

Refining the Treatment Paradigm Through Targeted Molecular Pathways

Dr Agarwala outlines the future of cancer treatment as more molecular targets and targeted therapies are identified.